News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
692,529 Results
Type
Article (39381)
Company Profile (247)
Press Release (652901)
Section
Business (204026)
Career Advice (2005)
Deals (35405)
Drug Delivery (93)
Drug Development (80941)
Employer Resources (169)
FDA (16133)
Job Trends (14828)
News (344875)
Policy (32473)
Tag
Academia (2535)
Alliances (49313)
Alzheimer's disease (1314)
Approvals (16117)
Artificial intelligence (199)
Bankruptcy (357)
Best Places to Work (11637)
Biotechnology (175)
Breast cancer (225)
Cancer (1710)
Cardiovascular disease (128)
Career advice (1669)
CAR-T (121)
Cell therapy (353)
Clinical research (65244)
Collaboration (659)
Compensation (370)
COVID-19 (2563)
C-suite (160)
Data (1629)
Diabetes (211)
Diagnostics (6282)
Earnings (85436)
Employer resources (146)
Events (110862)
Executive appointments (564)
FDA (17034)
Funding (602)
Gene therapy (245)
GLP-1 (648)
Government (4357)
Healthcare (18767)
Infectious disease (2674)
Interviews (310)
IPO (16460)
Job creations (3627)
Job search strategy (1420)
Layoffs (437)
Legal (7885)
Lung cancer (255)
Manufacturing (235)
Medical device (13261)
Medtech (13266)
Mergers & acquisitions (19320)
Metabolic disorders (548)
Neuroscience (1715)
NextGen: Class of 2025 (6509)
Non-profit (4475)
Northern California (2090)
Obesity (306)
Opinion (193)
Patents (162)
People (56828)
Phase I (20316)
Phase II (28744)
Phase III (21397)
Pipeline (711)
Postmarket research (2562)
Preclinical (8575)
Radiopharmaceuticals (241)
Rare diseases (321)
Real estate (5897)
Regulatory (21917)
Research institute (2311)
Resumes & cover letters (349)
Southern California (1791)
Startups (3567)
United States (18436)
Vaccines (611)
Weight loss (208)
Date
Today (11)
Last 7 days (593)
Last 30 days (2481)
Last 365 days (34397)
2025 (4427)
2024 (35217)
2023 (40076)
2022 (51173)
2021 (55711)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (716)
Arizona (211)
Asia (37505)
Australia (6132)
California (4761)
Canada (1715)
China (392)
Colorado (217)
Connecticut (230)
Europe (80384)
Florida (688)
Georgia (165)
Illinois (455)
Indiana (259)
Japan (121)
Maryland (739)
Massachusetts (3602)
Michigan (198)
Minnesota (334)
New Jersey (1347)
New York (1359)
North Carolina (833)
Northern California (2090)
Ohio (173)
Pennsylvania (1098)
South America (1093)
Southern California (1791)
Texas (701)
Utah (143)
Washington State (467)
692,529 Results for "teneobio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Amgen Successfully Completes Acquisition Of Teneobio, Inc.
Amgen (NASDAQ: AMGN) today announced that it has successfully completed its previously announced acquisition of Teneobio, Inc. (Teneobio).
October 19, 2021
·
9 min read
Deals
Newly-Formed Ancora Biotech Will Continue Operations of Teneobio Spin-offs After Successful Acquisition of Teneobio by Amgen
Ancora Biotech announced, in connection with the closing of the acquisition of Teneobio, Inc., by Amgen Inc., that Teneobio’s former shareholders and their representatives will provide oversight of three previous affiliates of Teneobio, including TeneoTwo, Inc. (TNB-486, anti-CD19xCD3), TeneoFour, Inc. (anti-CD38 enzyme inhibitor TNB-738) and TeneoTen, Inc. (anti-HBVxCD3).
October 27, 2021
·
2 min read
Press Releases
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
February 12, 2025
·
6 min read
Press Releases
Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.
January 23, 2025
·
5 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
February 3, 2025
·
7 min read
Press Releases
NanoViricides, Inc. Has Filed its Quarterly Report
February 20, 2025
·
12 min read
Press Releases
Windtree Therapeutics, Inc. Announces Reverse Stock Split
February 19, 2025
·
7 min read
Press Releases
111, Inc. Regains Compliance with NASDAQ Requirement
February 11, 2025
·
3 min read
Press Releases
Kronos Advanced Technologies Inc. ($KNOS) Confirms Ownership and Shareholder Updates for KronosMD, Inc.
January 27, 2025
·
13 min read
Biotech Bay
Teneobio’s Clinical Candidate, TNB-409, is a Selective IL-2 Receptor Bispecific Agonist for the Treatment of Solid Tumors
Teneobio, Inc., a clinical stage biotech company focused on the discovery and development of novel multi-specific biotherapeutic antibodies, announced today the publication of its bispecific human heavy chain only antibody (TNB-409) with selective IL-2βγ receptor heterodimeric agonist activity in Scientific Reports ( www.nature.com/articles/s41598-021-90096-8 ).
May 19, 2021
·
2 min read
1 of 69,253
Next
